Rallybio Corp. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

22.35 k

Shareholding (Mar 2025)

FII

8.04%

Held by 27 FIIs

DII

24.62%

Held by 17 DIIs

Promoter

53.97%

How big is Rallybio Corp.?

22-Jun-2025

As of Jun 18, Rallybio Corp. has a market capitalization of 14.07 million, with net sales of 0.85 million and a net loss of 48.19 million over the latest four quarters. Shareholder's funds are 61.65 million, and total assets amount to 68.11 million.

What does Rallybio Corp. do?

22-Jun-2025

Rallybio Corp. is a micro-cap company in the miscellaneous industry, reporting net sales of $0 million and a net loss of $9 million as of March 2025, with a market cap of $14.07 million. Key metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of -89.11%.

Is Rallybio Corp. technically bullish or bearish?

20-Sep-2025

As of September 8, 2025, Rallybio Corp. is in a mildly bearish trend, with daily moving averages and weekly RSI indicating bearish momentum, despite some mild bullish signals from the MACD and Bollinger Bands, and it has underperformed the S&P 500 with a year-to-date return of -37.58%.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Miscellaneous

Market cap

USD 25 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.99

Return on Equity

-86.92%

Price to Book

0.54

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Jun 2025)

Net Profit:

-10 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

29.81%

6 Months

138.52%

1 Year

-20.32%

2 Years

-73.18%

3 Years

-86.7%

4 Years

-92.44%

5 Years

0.0%

Rallybio Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Rallybio Corp. technically bullish or bearish?

As of 8 September 2025, the technical trend for Rallybio Corp. has changed from sideways to mildly bearish. The current stance is bearish, primarily driven by the daily moving averages indicating a mildly bearish position and the weekly RSI showing bearish momentum. Although the weekly MACD and Bollinger Bands suggest mild bullishness, they are overshadowed by the overall bearish signals from the daily indicators. The stock has underperformed significantly against the S&P 500, with a year-to-date return of -37.58% compared to the S&P 500's 12.22%....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-46.54%

EBIT Growth (5y)

-259.43%

EBIT to Interest (avg)

-53.42

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.01

Sales to Capital Employed (avg)

0.01

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

93.30%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.30

EV to EBIT

0.75

EV to EBITDA

0.76

EV to Capital Employed

37.94

EV to Sales

-37.94

PEG Ratio

Dividend Yield

ROCE (Latest)

5037.90%

ROE (Latest)

-89.11%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 19 Schemes (13.37%)

Foreign Institutions

Held by 27 Foreign Institutions (8.04%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -33.33% vs 0.00% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 40.12% vs 12.90% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.20",
          "val2": "0.30",
          "chgp": "-33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.30",
          "val2": "-17.00",
          "chgp": "51.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.70",
          "val2": "-16.20",
          "chgp": "40.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-39,419.80%",
          "val2": "-56,973.20%",
          "chgp": "1,755.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 22.52% vs -11.84% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-60.40",
          "val2": "-78.80",
          "chgp": "23.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-57.80",
          "val2": "-74.60",
          "chgp": "22.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-95,119.50%",
          "val2": "0.00%",
          "chgp": "-9,511.95%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.20

0.30

-33.33%

Operating Profit (PBDIT) excl Other Income

-8.30

-17.00

51.18%

Interest

0.00

Exceptional Items

-1.70

0.00

Consolidate Net Profit

-9.70

-16.20

40.12%

Operating Profit Margin (Excl OI)

-39,419.80%

-56,973.20%

1,755.34%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is -33.33% vs 0.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 40.12% vs 12.90% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.60

0.00

Operating Profit (PBDIT) excl Other Income

-60.40

-78.80

23.35%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-57.80

-74.60

22.52%

Operating Profit Margin (Excl OI)

-95,119.50%

0.00%

-9,511.95%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 22.52% vs -11.84% in Dec 2023

All Annual Results

Company CV

About Rallybio Corp.

Rallybio Corp.

Miscellaneous

No Details Available.

Company Coordinates

No Company Details Available

Rallybio Corp.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Rallybio Corp.?

Watch in Real-Time

What does Rallybio Corp. do?

Is Rallybio Corp. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Rallybio Corp. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Rallybio Corp.

Company Coordinates